SCHEMBL535708

SCHEMBL535708

COP(=O)(CC(=O)ONC(=O)OCc1ccccc1)OC

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.49
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
CA9 Q16790 2/20 0.49
KYNU Q16719 1/20 0.47
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
ALDH1A1 P00352 2/20 0.44
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ELANE P08246 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPK1 P28482 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CPB1 P15086 1/20 0.42
POLB P06746 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4465319 0.84 ALDH1A1 (0.56) KYNURAB9AALDH1A1LMNAKMT2A
SCHEMBL1951310 0.80 CA12 (0.56) CA12CA1CA2CA9NPC1
SCHEMBL27346972 0.79 CA12 (0.59) CA12CA1CA2CA9NPC1
SCHEMBL9112414 0.79 LMNA (0.56) KYNUNPC1RAB9AALDH1A1LMNA
SCHEMBL7378816 0.78 CA12 (0.58) CA12CA1CA2CA9NPC1
SCHEMBL27592314 0.78 ALDH1A1 (0.66) CA12CA1CA2CA9NPC1
SCHEMBL27972030 0.77 ELANE (0.51) CA12CA1CA2CA9KYNU
SCHEMBL8061583 0.77 CA12 (0.54) CA12CA1CA2CA9NPC1
SCHEMBL7415486 0.77 CA12 (0.56) CA12CA1CA2CA9NPC1
SCHEMBL7376134 0.77 CA12 (0.56) CA12CA1CA2CA9NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113195053-A Amino acid compounds and methods of use 普利安特治疗公司 2021-07-30 CN disclosed
EP-3681875-A1 CYCLIC PEPTIDE ANTIBIOTICS H. Hoffnabb-La Roche Ag (CH) 2020-07-22 EP disclosed
WO-2019052545-A1 CYCLIC PEPTIDE ANTIBIOTICS F. HOFFMANN-LA ROCHE AG (CH) 2019-03-21 WO disclosed
WO-2018149419-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS, INC. (US) 2018-08-23 WO disclosed
EP-2414352-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-02-08 EP disclosed
WO-2010117704-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-10-14 WO disclosed